NewLab has participated in over 200 Phase II-IV clinical trials. Our team of investigators, nurse coordinators, support staff and managers are all GCP-certified and are supported by over a decade of experience in clinical trials services.
We are committed to providing the highest-quality clinical trial service in the business. Our goal is for you to feel like our only client, and as such, you can expect:
- Courteous and timely customer service from a dedicated trials administrator
- Quick turnaround time for contract and budget approvals (<1 week), as well as regulatory and ethics documents
- Professional service and impeccable results from our team of capable and highly-trained nurse coordinators
- Efficient patient recruitment, achieved through a formal recruiting strategy specific to your project and the dedication of our Recruitment Coordinator
- That our dedicated Data Entry Specialist will complete data entry into your EDC system by the end of the next business day after each patient visit
- Peace of mind knowing that our investigators make the well-being of your patients and the success of your trial their number 1 priorities!
NewLab Clinical Research collaborates with industry sponsors and CRO’s to perform clinical research trials in
- Dermatology
- Psychiatry
- Oncology
- Gastroenterology
- Family Medicine
NewLab has performed extensive work in the field of biologic treatments, however we also have experience with oral and topical pharmaceutical products, medical device trials, and clinical research for natural health products.
Genetically Enhanced Trials
NewLab is uniquely positioned in the industry to combine clinical research with in-house genetic and genomic services to effect genetically enhanced trials...
NewLab is uniquely positioned in the industry to combine clinical research with in-house genetic and genomic services to effect genetically enhanced trials. Our pharmacogenomics services can help you:
- Identify responder and non-responder groups
- Identify genetic safety biomarkers
- Improve trial design
- Reduce product development time
- Recover failed drugs or rescue drugs in peril
These can be achieved through any combination of the following resources:
NewLab’s Genetic and Genomic Services
The state-of-the-art genetics capabilities of our Diagnostics and Genomics facility are available on site! Our GLP-compliant and CAP-certified facility can provide SNP genotypic and GWAS services. For a more information on our genetics offerings, please consult the Diagnostics and Genomics pages of this site.
Newfoundland and Labrador Founder Population
As a result of unique social, demographic, and economic influences, the Newfoundland and Labrador population has produced several genetic isolates characterized by large kindreds and a high coefficient of kinship. Genetic homogeneity resulting from founder effects with little environmental variability provides the opportunity to identify genes in Mendelian and complex diseases. The Newfoundland and Labrador Founder Population is internationally recognized and has been ranked 6th in the world in its significance for genetics research (Parfrey et al. KI 2002; Service S et al. Nat Genet 2006).
Heritability and Genetic Linkage Resources
NewLab collaborates with the Population Therapeutics Research Group (PTRG) St John’s Canada (http://www.med.mun.ca/ptrg/) which provides researchers and research companies with better access to the Newfoundland and Labrador population, prescription, and clinical health data. In about 10 – 20 minutes, their software is able to automatically generate a patient’s complete family pedigree within a 70% degree of accuracy; something that could take months to complete manually. For researchers, this information is a powerful tool in identifying potential genetic predispositions and potential genetic linkages to conditions and diseases.
Electronic Health Record
The Newfoundland and Labrador Centre for Health Information (NLCHI) has become the most comprehensive health information centre of its kind in Canada, and is a model for other jurisdictions. The Research and Evaluation Division of NLCHI prepares and analyzes statistical health information from databases of coded information. This division works closely with NewLab to carry out applied health research for industry. Perhaps their most significant undertaking from the pharmaceutical industry’s perspective is the provincial pharmacy network. This network connects all pharmacies across the province to electronically track and analyze drug prescription information. Our ability to associate prescription information with clinical results will provide great insight into drug effectiveness, adverse effects, etc.
NewLab is uniquely positioned in the industry to combine clinical research with in-house genetic and genomic services to effect genetically enhanced trials...
|
|
|
|
|